102 related articles for article (PubMed ID: 11244986)
21. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
22. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
[TBL] [Abstract][Full Text] [Related]
23. Estimation of PR and ER by immunocytochemistry in breast cancer. Comparison with radioligand binding methods.
Seymour L; Meyer K; Esser J; MacPhail AP; Behr A; Bezwoda WR
Am J Clin Pathol; 1990 Oct; 94(4 Suppl 1):S35-40. PubMed ID: 1699410
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
Hicks D; Dell'Orto P; Falzon M; Hoff KD; Levy YY; McMahon L; Miller K; Russo L; Viale G
Appl Immunohistochem Mol Morphol; 2017; 25(5):313-319. PubMed ID: 26657878
[TBL] [Abstract][Full Text] [Related]
25. Study on breast carcinoma Her2/neu and hormonal receptors status assessed by automated images analysis systems: ACIS III (Dako) and ScanScope (Aperio).
Słodkowska J; Filas V; Buszkiewicz E; Trzeciak P; Wojciechowski M; Koktysz R; Staniszewski W; Breborowicz J; Rojo MG
Folia Histochem Cytobiol; 2010 Jan; 48(1):19-25. PubMed ID: 20529811
[TBL] [Abstract][Full Text] [Related]
26. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
27. Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies.
Estes PA; Suba EJ; Lawler-Heavner J; Elashry-Stowers D; Wei LL; Toft DO; Sullivan WP; Horwitz KB; Edwards DP
Biochemistry; 1987 Sep; 26(19):6250-62. PubMed ID: 3689773
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
[TBL] [Abstract][Full Text] [Related]
29. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.
Press MF; Xu SH; Wang JD; Greene GL
Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797
[TBL] [Abstract][Full Text] [Related]
30. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
31. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J
Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256
[TBL] [Abstract][Full Text] [Related]
32. Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?
Foley NM; Coll JM; Lowery AJ; Hynes SO; Kerin MJ; Sheehan M; Brodie C; Sweeney KJ
Pathol Oncol Res; 2018 Oct; 24(4):881-884. PubMed ID: 28891017
[TBL] [Abstract][Full Text] [Related]
33. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints.
Sasaki M; Morimoto K; Koh M; Wakasa K; Haba T; Kinoshita H
Acta Cytol; 2002; 46(6):1056-60. PubMed ID: 12462082
[TBL] [Abstract][Full Text] [Related]
34. [Preparation and characterization of monoclonal antibodies against Cryptosporidium parvum].
Zong H; Li W; Zhang X; Yu S
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(4):279-82. PubMed ID: 12078258
[TBL] [Abstract][Full Text] [Related]
35. Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay.
Wilbur DC; Willis J; Mooney RA; Fallon MA; Moynes R; di Sant'Agnese PA
Mod Pathol; 1992 Jan; 5(1):79-84. PubMed ID: 1371874
[TBL] [Abstract][Full Text] [Related]
36. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
[TBL] [Abstract][Full Text] [Related]
37. [Preparation of monoclonal antibodies against chorionic gonadotropin receptor and study of its characteristics].
Han S; Chen M; Peng Z; Liu S; Cao Z
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):372-5. PubMed ID: 1814814
[TBL] [Abstract][Full Text] [Related]
38. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
Kiang DT; Kollander R
J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
[TBL] [Abstract][Full Text] [Related]
39. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
Schenck U; Jütting U; Eiermann W
Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
[TBL] [Abstract][Full Text] [Related]
40. [Preparation and identification of anti-Trichomonas vaginalis monoclonal antibodies].
Gao XZ; Mao YD; Tang ZH; Yu C; Zhu YH; Yang FY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(2):139-42. PubMed ID: 1394911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]